General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-15 | 2024-03 | -0.66 | -0.53 | 0.13 | 19.70% |
2024-02-14 | 2023-12 | -0.43 | -0.56 | -0.13 | -30.23% |
2023-11-14 | 2023-09 | -0.75 | -0.48 | 0.27 | 36.00% |
2023-09-28 | 2023-06 | -0.59 | -0.91 | -0.32 | -54.24% |
2023-05-16 | 2023-03 | -0.59 | -0.63 | -0.04 | -6.78% |
2023-02-14 | 2022-12 | -0.77 | -0.66 | 0.11 | 14.29% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-09 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-07 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-08-06 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-29 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-08 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-12 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-04-10 | DE VEER ROBERT K JR | Director | 40.85K | Purchase |
2023-12-03 | DUNTON ALAN WILLIAM | Director | 45.07K | Sale |
2015-12-07 | HOROVITZ ZOLA P | Director | 250.67K | Stock Award(Grant) |
2023-06-19 | HULL JOSEPH STANLEY | Director | 47.59K | Stock Award(Grant) |
2023-06-19 | MANNING ANTHONY M | Director | 36.69K | Stock Award(Grant) |
2023-06-19 | MORRIS ARLENE M | Director | 45.09K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 382.55K | 803.36K | 3.20% |
2023-06-29 | Blackrock Inc. | 246.79K | 518.26K | 2.07% |
2023-06-29 | Geode Capital Management, LLC | 66.28K | 139.19K | 0.55% |
2023-06-29 | State Street Corporation | 30.30K | 63.62K | 0.25% |
2023-06-29 | Bridgeway Capital Management, Inc. | 26.12K | 54.86K | 0.22% |
2023-06-29 | Montis Financial, LLC | 20.96K | 44.02K | 0.18% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 246.70K | 518.08K | 2.07% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 127.72K | 263.11K | 1.07% |
2023-06-29 | Vanguard Extended Market Index Fund | 115.67K | 242.90K | 0.97% |
2023-05-30 | Fidelity Extended Market Index Fund | 40.49K | 99.21K | 0.34% |
2023-06-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 24.80K | 52.08K | 0.21% |
2023-05-30 | Fidelity Total Market Index Fund | 10.93K | 26.78K | 0.09% |
Split | Date |
---|---|
1 : 25 | 2022-08-31 |
0.1 : 1 | 2010-09-27 |
$PTN just 2 weeks ago this was below .89 and 150k in volume. It is growing rapidly in cost per share and in volume, which shows it is growing fast. It is now over 2 million now and above $1, so it is at a climb, and will be growing passed $1.20 mark do to FDA approval and future benefits.
I got a sell order for 8 dollars guys help yourself lol
Just got 7k shares
We have a take off.
Imma be- black eyed peas
Q3 transcript about the $60 million
Steve Wills -- Executive Vice President, Chief Financial Officer, and Chief Operating Officer
Sure. Thanks, Joe. The -- if everything goes as planned, the $60 million, it would actually be recognized in the second quarter, say, the PDUFA date of June 23. The actual cash we'll receive sometime in July.
The -- that recognition is 100% revenue.